Phase 2 Smoking Cessation Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
Evaluating Smoking Cessation Interventions for PWH in South Africa
Comorbidities and Coexisting ConditionsSmoking CessationHIV
Johns Hopkins University660 enrolled1 locationNCT05413122
Recruiting
Phase 2
Multi-Site Trial of Tirzepatide for Smoking Cessation
Smoking CessationSmoking Behaviors
University of Southern California300 enrolled4 locationsNCT07602699
Recruiting
Phase 2Phase 3
Empowering Cessation ACS South Region
Smoking Cessation
University of Oklahoma400 enrolled1 locationNCT06820034
Recruiting
Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
cardiopulmonary diseaseSmoking CessationInpatient
Baystate Medical Center424 enrolled1 locationNCT05733767
Recruiting
Phase 2
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
Smoking CessationTobacco Use Disorder
University of California, Los Angeles64 enrolled1 locationNCT06617312
Recruiting
Phase 1Phase 2
Overcoming Nicotine Dependence to Enable Quitting
Smoking CessationSmoking BehaviorsNicotine Dependence+2 more
Rush University Medical Center780 enrolled1 locationNCT05513872